Celanese (CE)
(Delayed Data from NYSE)
$130.03 USD
-2.53 (-1.91%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $130.08 +0.05 (0.04%) 6:56 PM ET
5-Strong Sell of 5 5
B Value C Growth F Momentum C VGM
Income Statements
Fiscal Year end for Celanese Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 10,940 | 9,673 | 8,537 | 5,655 | 6,297 |
Cost Of Goods | 8,337 | 7,293 | 5,855 | 4,362 | 4,691 |
Gross Profit | 2,603 | 2,380 | 2,682 | 1,293 | 1,606 |
Selling & Adminstrative & Depr. & Amort Expenses | 916 | 1,002 | 736 | 629 | 772 |
Income After Depreciation & Amortization | 1,687 | 1,378 | 1,946 | 664 | 834 |
Non-Operating Income | 216 | 448 | 393 | 1,696 | 269 |
Interest Expense | 720 | 405 | 91 | 109 | 115 |
Pretax Income | 1,183 | 1,421 | 2,248 | 2,251 | 988 |
Income Taxes | -790 | -489 | 330 | 247 | 124 |
Minority Interest | 4 | 8 | 6 | 7 | 6 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1,973 | 1,910 | 1,918 | 2,004 | 864 |
Extras & Discontinued Operations | -9 | -8 | -22 | -12 | -6 |
Net Income (GAAP) | 1,960 | 1,894 | 1,890 | 1,985 | 852 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 2,426 | 1,856 | 2,324 | 1,020 | 1,190 |
Depreciation & Amortization (Cash Flow) | 739 | 478 | 378 | 356 | 356 |
Income After Depreciation & Amortization | 1,687 | 1,378 | 1,946 | 664 | 834 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 109.40 | 109.20 | 112.10 | 118.50 | 124.70 |
Diluted EPS Before Non-Recurring Items | 8.92 | 15.88 | 18.12 | 7.64 | 9.53 |
Diluted Net EPS (GAAP) | 17.92 | 17.34 | 16.86 | 16.75 | 6.84 |
Fiscal Year end for Celanese Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 2,651.00 | 2,611.00 | 2,569.00 | 2,723.00 | 2,795.00 |
Cost Of Goods | 2,010.00 | 2,057.00 | 1,956.00 | 2,050.00 | 2,109.00 |
Gross Profit | 641.00 | 554.00 | 613.00 | 673.00 | 686.00 |
SG&A, R&D, and Dept/Amort Expenses | 391.00 | 344.00 | 354.00 | -169.00 | 351.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 250.00 | 210.00 | 259.00 | 842.00 | 335.00 |
Non-Operating Income | 107.00 | 116.00 | 51.00 | 50.00 | 63.00 |
Interest Expense | 174.00 | 169.00 | 178.00 | 178.00 | 182.00 |
Pretax Income | 183.00 | 157.00 | 132.00 | 714.00 | 216.00 |
Income Taxes | 29.00 | 33.00 | -575.00 | -236.00 | -4.00 |
Minority Interest | -2.00 | 3.00 | 3.00 | -2.00 | 1.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 154.00 | 124.00 | 707.00 | 950.00 | 220.00 |
Extras & Discontinued Operations | -1.00 | 0.00 | -6.00 | -1.00 | 1.00 |
Net Income (GAAP) | 155.00 | 121.00 | 698.00 | 951.00 | 220.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 109.50 | 109.50 | 109.50 | 109.40 | 109.30 |
Diluted EPS Before Non-Recurring Items | 2.38 | 2.08 | 2.24 | 2.50 | 2.17 |
Diluted Net EPS (GAAP) | 1.41 | 1.10 | 6.39 | 8.69 | 2.01 |